Dean M. Hartley

12.7k citations

61 papers · 9.6k indexed · 6 hit papers · h-index 40

Physiology top 0.1%
- Alzheimer's disease research and treatments 27
Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments 7
Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research 15
Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments 7
Biological Psychiatry top 2%
Molecular Biology
- Prion Diseases and Protein Misfolding 8
- S100 Proteins and Annexins 4
Pharmacology
- Cholinesterase and Neurodegenerative Diseases 6
Psychiatry and Mental health
- Dementia and Cognitive Impairment Research 6
Computational Theory and Mathematics
- Computational Drug Discovery Methods 5

Co-authors: Dominic M. Walsh Dennis J. Selkoe Hilal A. Lashuel David B. Teplow Peter T. Lansbury Thomas Walz Benjamin M. Petre Thekla S. Diehl
Cited by: Physiology Neurology Cellular and Molecular Neuroscience
Journals: Nature (2 papers)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (3 papers)
Partner nations: United States Australia Canada

In The Last Decade

Dean M. Hartley

60 papers receiving 9.4k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Alzheimer s & Dementia
2002 Nature
2002 Nature
1999 Journal of Biological Chemistry
1999 PubMed
1999 Journal of Neuroscience

Peers

Countries citing papers authored by Dean M. Hartley

Since Specialization

Citations

This map shows the geographic impact of Dean M. Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean M. Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean M. Hartley more than expected).

Fields of papers citing papers by Dean M. Hartley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean M. Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean M. Hartley. The network helps show where Dean M. Hartley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dean M. Hartley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dean M. Hartley Line = papers co-authored together Dean M. Hartley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical utility of genome sequencing in autism: illustrative examples from a genomic research study Journal of Medical Genetics ·Thanuja Selvanayagam,Ny Hoang,Ege Sarikaya,Jennifer Howe,Carolyn Russell,Alana Iaboni,Morgan Quirbach,Christian R. Marshall,Péter Szatmári,Evdokia Anagnostou,Jacob Vorstman,Dean M. Hartley,Stephen W. Scherer	2025	1
2	Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association Journal of Nuclear Medicine ·Keith A. Johnson,Satoshi Minoshima,Nicolaas I. Bohnen,Kevin Donohoe,Norman L. Foster,Peter Herscovitch,Jason Karlawish,Christopher C. Rowe,María C. Carrillo,Dean M. Hartley,Saima Hedrick,Virginia Pappas,William Thies	2013	213
3	Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody Molecular Neurodegeneration ·Katherine L. Youmans,Leon M. Tai,Takahisa Kanekiyo,W. Blaine Stine,Sara-Claude Michon,Evelyn Nwabuisi‐Heath,Arlene M. Manelli,Yifan Fu,Sean M. Riordan,William A. Eimer,Lester I. Binder,Guojun Bu,Chunjiang Yu,Dean M. Hartley,Mary Jo LaDu	2012	143
4	Endogenous Galanin Protects Mouse Hippocampal Neurons Against Amyloid Toxicity in vitro via Activation of Galanin Receptor-2 Journal of Alzheimer s Disease ·Caroline R. Elliott‐Hunt,Fiona E. Holmes,Dean M. Hartley,Sylvia E. Perez,Elliott J. Mufson,David Wynick	2011	31
5	Preparation and characterization of toxic Aβ aggregates for structural and functional studies in Alzheimer's disease research Nature Protocols ·Asad Jan,Dean M. Hartley,Hilal A. Lashuel	2010	222
6	Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation Journal of Biological Chemistry ·Dean M. Hartley,Chaohui Zhao,Austin C. Speier,Gavitt A. Woodard,Shaomin Li,Zongli Li,Thomas Walz	2008	78
7	Gemfibrozil Ameliorates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Independent of Peroxisome Proliferator-Activated Receptor-α Molecular Pharmacology ·Subhajit Dasgupta,Avik Roy,Malabendu Jana,Dean M. Hartley,Kalipada Pahan	2007	74
8	Alzheimer’s Disease ß–Amyloid (Aß) Mediates Metal–Dependent Human Lens Protein Aggregation and Light Scattering Investigative Ophthalmology & Visual Science ·Lianwu Fu,Eleanor A. Blakely,Madeleine Marcus,K.A. Bjornstad,B. Due,M. Rehrmann,Dean M. Hartley,George M. Thurston,L.T. Chylack,L.E. Goldstein	2005	1
9	Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration Neurobiology of Disease ·Brian M. Whalen,Dennis J. Selkoe,Dean M. Hartley	2005	65
10	New Class of Inhibitors of Amyloid-β Fibril Formation Journal of Biological Chemistry ·Hilal A. Lashuel,Dean M. Hartley,David Balakhaneh,Aneel K. Aggarwal,Saul Teichberg,David J.E. Callaway	2002	125
11	Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in micebreakdown → Nature ·Shan Zhu,Irina G. Stavrovskaya,Martin Drozda,Betty Y.S. Kim,Victor Ona,Mingwei Li,Satinder S. Sarang,Allen S. Liu,Dean M. Hartley,Du Chu Wu,Steven R. Gullans,Robert J. Ferrante,Serge Przedborski,Bruce S. Kristal,Robert M. Friedlander	2002	877
12	Presenilin Affects Arm/β-Catenin Localization and Function in Drosophila Developmental Biology ·Elizabeth Noll,Miguel Medina,Dean M. Hartley,Jianhua Zhou,Norbert Perrimon,Kenneth S. Kosik	2000	46
13	A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nature Structural Biology ·Youcef Fezoui,David B. Teplow,Dean M. Hartley,Dominic M. Walsh,Dennis J. Selkoe,John J. Osterhout	2000	112
14	Expression of the calcium-binding protein, parvalbumin, in cultured cortical neurons using a HSV-1 vector system enhances NMDA neurotoxicity Molecular Brain Research ·Dean M. Hartley,Rachael L. Neve,J. H. Bryan,Donna Ullrey,Sun.-Y Bak,Phung Lang,Alfred I. Geller	1996	15
15	AMPA receptor activation potentiates zinc neurotoxicity Neuron ·John H. Weiss,Dean M. Hartley,Jae‐Young Koh,Dennis W. Choi	1993	231
16	Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin Neuron ·Hannah Monyer,Rona G. Giffard,Dean M. Hartley,Laura L. Dugan,Mark P. Goldberg,Dennis W. Choi	1992	72
17	21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures Neuron ·Hannah Monyer,Dean M. Hartley,Dennis W. Choi	1990	177
18	Folate interactions with cerebral G proteins Neurochemical Research ·Dean M. Hartley,S. Robert Snodgrass	1990	7
19	Automated determination of excitatory amino acid neurotoxicity in cortical culture Journal of Neuroscience Methods ·Jeffrey Klingman,Dean M. Hartley,Dennis W. Choi	1990	6
20	The measurement of gamma-glutamyl hydrolase (conjugase) activity in rat brain Neurochemical Research ·Dean M. Hartley,S. Robert Snodgrass,Peggy A. Bradshaw	1988	1

About Dean M. Hartley

Dean M. Hartley is a scholar working on Physiology, Cellular and Molecular Neuroscience and Geriatrics and Gerontology, having authored 61 papers that have together received 9.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (27 papers), Neuroscience and Neuropharmacology Research (15 papers), Prion Diseases and Protein Misfolding (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Dementia and Cognitive Impairment Research (6 papers), Computational Drug Discovery Methods (5 papers) and S100 Proteins and Annexins (4 papers). The work is most often cited by research in Physiology (5.6k citations), Neurology (1.3k citations) and Cellular and Molecular Neuroscience (2.1k citations). Dean M. Hartley has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Dominic M. Walsh, Dennis J. Selkoe, Hilal A. Lashuel, David B. Teplow, Peter T. Lansbury, Thomas Walz, Benjamin M. Petre, Thekla S. Diehl, Peter Vassilev and Youcef Fezoui. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact